Regulatory Alerts2026-04-29
Added · Updated
FEPD-1 Circular Letter No. 06: Instructions Regarding Opening of LC/TT for Import of Supplement Products Without Registration or Prior Approval of the Directorate General of Drug Administration
The Foreign Exchange Policy Department-1 of Bangladesh Bank forwards a letter from the Directorate General of Drug Administration dated April 21, 2026, to all approved dealer banks. The document instructs banks to take necessary measures regarding the opening of Letters of Credit or Telegraphic Transfers for the import of supplement products that lack registration or prior approval from the Directorate General of Drug Administration.
FOREIGN EXCHANGE POLICY DEPARTMENT-1 BANGLADESH BANK HEAD OFFICE DHAKA.
FEPD-1 Circular Letter No. 06 Date: 16 Boishakh 1433 29 April 2026
To: All Approved Dealer Banks engaged in Foreign Exchange Transactions Head Office / Principal Office.
Subject: Issuance of instructions regarding the opening of LC/TT for the import of supplement products without registration or prior approval of the Directorate General of Drug Administration.
Dear Sir,
With reference to the subject cited above, a letter from the Directorate General of Drug Administration-1, under the Health Services Division of the Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh, dated 21 April 2026, bearing number 45.00.0000.182.99.002.24(Ang).114, is attached herewith for your information and necessary action.
Yours faithfully,
Enclosed: As per text.
(Md. Harun-Or-Rashid) Director (FEPD-1) Phone: 9530123
More like this from BB
BB published 18 documents in the last 30 days. We email you each new one the day it's published.